Michael M Abecassis
Overview
Explore the profile of Michael M Abecassis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
5535
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Guo K, Heilman R, Poggio E, Taber D, Marsh C, et al.
Clin J Am Soc Nephrol
. 2021 Oct;
16(10):1539-1551.
PMID: 34620649
Background And Objectives: Subclinical acute rejection is associated with poor outcomes in kidney transplant recipients. As an alternative to surveillance biopsies, noninvasive screening has been established with a blood gene...
2.
Grewal A, Friedewald J, Abecassis M
Am J Transplant
. 2020 Sep;
21(3):1346-1347.
PMID: 32946671
No abstract available.
3.
Qiu L, Lai X, Wang J, Yeap X, Han S, Zheng F, et al.
Kidney Int
. 2020 Aug;
98(6):1489-1501.
PMID: 32822703
Delayed graft function due to transplant ischemia/reperfusion injury adversely affects up to 50% of deceased-donor kidney transplant recipients. However, key factors contributing to the severity of ischemia/reperfusion injury remain unclear....
4.
Shah S, DeBerge M, Iovane A, Yan S, Qiu L, Wang J, et al.
Pathogens
. 2020 Jul;
9(8).
PMID: 32722544
Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces allograft viability. To...
5.
Yu S, Dangi A, Burnette M, Abecassis M, Thorp E, Luo X
Am J Transplant
. 2020 Jul;
21(2):515-524.
PMID: 32659030
We have previously shown that acute cytomegalovirus (CMV) infection disrupts the induction of transplantation tolerance. However, what impact acute CMV infection would have on the maintenance of established tolerance and...
6.
Lee D, Abecassis M, Friedewald J, Rose S, First M
Transplant Proc
. 2020 Jun;
52(10):3085-3089.
PMID: 32576474
An e-mail-based market research survey focused on high-volume US adult transplant centers was developed and implemented to assess surveillance based on United Network for Organ Sharing/Scientific Registry of Transplant Recipients...
7.
Heald-Sargent T, Forte E, Liu X, Thorp E, Abecassis M, Zhang Z, et al.
Transplantation
. 2020 Jan;
104(5):e118-e124.
PMID: 31996662
Cytomegalovirus (CMV) is a β-herpesvirus that establishes lifelong latency in infected hosts. Following transplantation of a latently infected organ, reactivation can occur and consists of a spectrum of clinically apparent...
8.
Naesens M, Friedewald J, Mas V, Kaplan B, Abecassis M
Transplantation
. 2019 Dec;
104(4):700-707.
PMID: 31815910
Noninvasive biomarkers are needed to monitor stable patients following kidney transplantation (KT), as subclinical rejection, currently detectable only with invasive surveillance biopsies, can lead to chronic rejection and graft loss....
9.
Liu X, Swaminathan S, Yan S, Engelmann F, Abbott D, VanOsdol L, et al.
J Gen Virol
. 2019 Oct;
100(12):1680-1694.
PMID: 31647403
CD34+ myeloid lineage progenitor cells are an important reservoir of latent human cytomegalovirus (HCMV), and differentiation to macrophages or dendritic cells (DCs) is known to cause reactivation of latent virus....
10.
McElroy L, Gillett E, Nguyen C, Holl J, Abecassis M, Ladner D
Clin Liver Dis (Hoboken)
. 2019 May;
7(2):29-31.
PMID: 31041023
No abstract available.